Mashup Score: 0 PubMed Esomeprazole covalently interacts with the cardiovascular enzyme dimethylarginine dimethylaminohydrolase: Insights into the cardiovascular risk of proton pump inhibitors – PubMed - Our study calls for pharmacovigilance studies to monitor adverse cardiovascular events in chronic PPI users. 123456 Joel Kahn MD, FACC Proton pump inhibitors interfere with NO production Read the full article here See more from Joel Kahn Share this article × facebook twitter email https://mashupmd.com/expert-articles-post/esomeprazole-covalently-interacts-with-the-cardiovascular-enzyme-dimethylarginine-dimethylaminohydrolase-insights-into-the-cardiovascular-risk-of-proton-pump-inhibitors-pubmed/ Copy Link
WSJ Coffee and Your Heart: The Impact May Be Different Than You Think #AtrialFibrillation #Cardiology Dr. Deepak L. Bhatt
OUP Academic Value of screening for the risk of sudden cardiac death in young competitive athletes #athletes #cardiotwitter EHJ Editor-in-Chief
PubMed 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Mana... Sam Tsimikas, MD
Journal of the American S Turning Up the Ethical Gain: The Importance of Accurate Echocardiographic Assessme... IANCARDIOLOGY
www.sciencedirect.com Habitual daily intake of a sweet and fatty snack modulates reward processing in hu... Pradeep Natarajan
Zoom Welcome! You are invited to join a webinar: Frontiers in Cardiovascular Science Se... #Cardiac #PrecisionMedicine Joseph C Wu, MD, PhD
www.bidmc.org BIDMC Research Guides FDA Action on Common Medical Device #SAFEAAA Eric Secemsky MD MSc
HMP Global Learning Netwo Novel High-Density Mapping Techniques for Atypical Atrial Flutter Characterization EP Lab Digest
Proton pump inhibitors interfere with NO production